Lupin recalls over 24,000 bottles of skin treatment drug from US
According to USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Lupin is recalling from the US and Puerto Rico over 24 thousand bottles of Fluocinolone Acetonide, Image source: Reuters